Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype Synapep BPC 157 Experienced Wichita Podiatrist Central Kansas Podiatry Associates BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Therapeutic peptides in the treatment of digestive inflammation: Current advances and future prospects ScienceDirect 1209_S7_article_14 BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health &